WPI 2232 (Tamoxifen 10 mg)

Pill imprint WPI 2232 has been identified as Tamoxifen citrate 10 mg.

Tamoxifen is used in the treatment of breast cancer, metastatic; breast cancer, adjuvant; breast cancer; breast cancer, prevention; breast cancer, male (and more), and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. There is positive evidence of human fetal risk during pregnancy. Tamoxifen 10 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for WPI 2232

Tamoxifen citrate 10 mg WPI 2232
Tamoxifen citrate
Imprint:
WPI
2232
Strength:
10 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Hormones/antineoplastics
Selective estrogen receptor modulators
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Pharmaceuticals, Inc.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)